Gasang, Harlene I.

HRN: 22-28-67  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2022
CEFUROXIME 1.5GM (VIAL)
12/26/2022
12/26/2022
IVT
1.5g
LD
Preop Prophylaxis
Waiting Final Action 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes